With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

The global pharmaceutical market size was valued at USD 1,607.07 billion in 2024 ... Technologies like artificial intelligence (AI), machine learning, big data analytics, and blockchain are ...

rising at a CAGR of 10.15% The global pharmaceutical R&D outsourcing market report consists of exclusive data on 44 vendors. Major players like Boehringer Ingelheim, Charles River Laboratories ...

CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

The Active Pharmaceutical Ingredient (API) Market report leverages tables, charts, and graphs to present data clearly and concisely ... an in-depth analysis of the leading players in the global Active ...

Adoption of CRM to streamline clinical data ... In Pharma Biotech Sectors AI CRM is poised to grow at the highest CAGR of 18.4% in the years to come in the pharma & biotech CRM software market.

Industry associations react to President Trump’s tariffs and what they could mean for the pharmaceutical supply chain.

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various factors.

Q4 2024 Earnings Call Transcript February 12, 2025 Ascendis Pharma A/S beats earnings expectations. Reported EPS is $-0.68699 ...